mewburn-logo-white mewburn-logo
  • MyMewburn
  • About us
    • About us
    • Working with our Munich Office
    • Our AI Strategy & Action Plan
    • Who we work with
    • How we work with our clients
    • The Mewburn Ellis culture
    • Community giving
    • Inclusion & diversity
      • Inclusion & diversity
      • Gender Pay Gap
      • Women in IP
    • Sustainability
    • Join Mewburn Ellis
      • Join Mewburn Ellis
      • Vacancies
    • Graduate training programme
    • Business partners
      • Business partners
      • Code of conduct
      • Diversity policy
      • Environmental policy
  • Our People
    • Our People
    • View All People
    • Our Leadership Team
  • About you
    • Who we work with
    • I'm an attorney/law firm
    • I'm a university/R&D
    • I'm a corporate
    • I'm an SME
    • I'm a start up/spin out
  • Which service?
    • Services
    • I want to patent an invention
      • I want to patent an invention
      • Chemistry Patents
      • Engineering Patents
      • Life Sciences Patents
      • Patent Disputes
      • Patent Renewals
      • European Patent Validations
      • Pharma Patent Extensions & Regulatory Exclusivity
    • I want to protect a brand
      • I want to protect a brand
      • Register a trade mark
      • Trade mark disputes
      • Trade mark renewals
      • I want to change a domain name
    • I want to protect my design
      • Register a Design
      • Design Renewals
    • I need help with contentious proceedings
      • Contentious proceedings
      • post grant proceedings
      • oppositions or appeals
      • IP litigation or disputes
      • The Unified Patent Court
    • I need some commercial advice
    • I need to validate my European patent
    • I want to renew my ip rights
  • Spotlight on
    • Health
      • Advanced therapeutics
      • Animal health
      • Bioinformatics
      • BioProcessing & Industrial BioTech
      • Digital Health
      • Future food
      • Medical technologies
      • Microbiome
      • Pharmaceuticals
      • Plants
      • Precision medicine
      • Speciality pharma
    • Technology
      • Artificial Intelligence (AI)
      • Bioinformatics
      • BioProcessing & Industrial BioTech
      • Digital Health
      • Future mobility
      • Green & sustainable technologies
      • Medical technologies
      • New Nuclear Technologies
      • Quantum Technology
      • Software
      • Space Technology
    • Industry
      • 2d materials
      • Automotive
      • Energy storage
      • Green tech
      • Marine & ocean engineering
      • Medical devices
      • Polymers
      • Pharmaceuticals
      • Plants
      • Speciality pharma
      • Synthetic biology
    • Intellectual property
      • Brexit
      • Green ip
      • Ip litigation
      • Oppositions - chemistry & materials
      • Oppositions - engineering & ICT
      • Oppositions - life sciences
      • UPC
      • Women in ip
  • Knowledge hub
    • Law & practice library
    • News, insights & features
    • Special reports
    • Films
    • Events and Webinars
  • Contact us
    • Offices
    • 8 Bishopsgate
    • Residencies
  • en
  • zh-hans
  • germany
  • ja
  • ko
  • MyMewburn
  • About us
    • About us
    • Working with our Munich Office
    • Our AI Strategy & Action Plan
    • Who we work with
    • How we work with our clients
    • The Mewburn Ellis culture
    • Community giving
    • Inclusion & diversity
      • Inclusion & diversity
      • Gender Pay Gap
      • Women in IP
    • Sustainability
    • Join Mewburn Ellis
      • Join Mewburn Ellis
      • Vacancies
    • Graduate training programme
    • Business partners
      • Business partners
      • Code of conduct
      • Diversity policy
      • Environmental policy
  • Our People
    • Our People
    • View All People
    • Our Leadership Team
  • About you
    • Who we work with
    • I'm an attorney/law firm
    • I'm a university/R&D
    • I'm a corporate
    • I'm an SME
    • I'm a start up/spin out
  • Which service?
    • Services
    • I want to patent an invention
      • I want to patent an invention
      • Chemistry Patents
      • Engineering Patents
      • Life Sciences Patents
      • Patent Disputes
      • Patent Renewals
      • European Patent Validations
      • Pharma Patent Extensions & Regulatory Exclusivity
    • I want to protect a brand
      • I want to protect a brand
      • Register a trade mark
      • Trade mark disputes
      • Trade mark renewals
      • I want to change a domain name
    • I want to protect my design
      • Register a Design
      • Design Renewals
    • I need help with contentious proceedings
      • Contentious proceedings
      • post grant proceedings
      • oppositions or appeals
      • IP litigation or disputes
      • The Unified Patent Court
    • I need some commercial advice
    • I need to validate my European patent
    • I want to renew my ip rights
  • Spotlight on
    • Health
      • Advanced therapeutics
      • Animal health
      • Bioinformatics
      • BioProcessing & Industrial BioTech
      • Digital Health
      • Future food
      • Medical technologies
      • Microbiome
      • Pharmaceuticals
      • Plants
      • Precision medicine
      • Speciality pharma
    • Technology
      • Artificial Intelligence (AI)
      • Bioinformatics
      • BioProcessing & Industrial BioTech
      • Digital Health
      • Future mobility
      • Green & sustainable technologies
      • Medical technologies
      • New Nuclear Technologies
      • Quantum Technology
      • Software
      • Space Technology
    • Industry
      • 2d materials
      • Automotive
      • Energy storage
      • Green tech
      • Marine & ocean engineering
      • Medical devices
      • Polymers
      • Pharmaceuticals
      • Plants
      • Speciality pharma
      • Synthetic biology
    • Intellectual property
      • Brexit
      • Green ip
      • Ip litigation
      • Oppositions - chemistry & materials
      • Oppositions - engineering & ICT
      • Oppositions - life sciences
      • UPC
      • Women in ip
  • Knowledge hub
    • Law & practice library
    • News, insights & features
    • Special reports
    • Films
    • Events and Webinars
  • Contact us
    • Offices
    • 8 Bishopsgate
    • Residencies
  • All topics
  • Forward
  • Artificial Intelligence
  • Battery Technologies
  • Bioinformatics
  • Brexit
  • Chemistry
  • Commercial Advice
  • Community
  • COVID-19
  • Designs
  • Energy Storage
  • Engineering
  • EU Unitary Patent / Unified Patent Court
  • FemTech
  • Future Food Tech
  • Future Mobility
  • Graphene & 2D Materials
  • Green Tech
  • ICT
  • Life Sciences
  • Litigation
  • Marine & Ocean Engineering
  • Materials
  • MedTech
  • Microbiome
  • Nature based materials
  • Nuclear
  • On-Demand
  • Oppositions
  • Patents
  • Pharmaceuticals
  • Plants
  • Polymers
  • Polymer recycling
  • Precision Medicine
  • Quantum Computing
  • SME
  • Software
  • Space Tech
  • Synthetic Biology
  • Trade Marks
Software IP – A Lunch and Learn Seminar for Startups and SMEs, Wednesday 19 March 2025
James Leach - February 17, 2025

Software IP – A Lunch and Learn Seminar for Startups and SMEs, Wednesday 19 March 2025

Join us for an insightful seminar at the Greater Manchester Digital Security Hub (DiSH), where ...

Protecting Copyright Holders In The Age Of AI
James Leach - December 5, 2024

Protecting Copyright Holders In The Age Of AI

In the rapidly evolving landscape of artificial intelligence (AI), the training data that fuels AI ...

IP Protection for software-based products- An Introduction for SMEs
James Leach - November 16, 2023

IP Protection for software-based products- An Introduction for SMEs

We are excited to launch our new software resource booklet — 'IP Protection for software-based ...

Quick guide to determining whether a software invention is patent eligible.
James Leach - August 16, 2023

Quick guide to determining whether a software invention is patent eligible.

In general, the main obstacle to obtaining patent protection for a new software invention is the ...

AI at the UKIPO – a more patent friendly approach?
James Leach - October 19, 2022

AI at the UKIPO – a more patent friendly approach?

The UKIPO recently issued new guidance relating to examining patent applications relating to ...

Obtaining patent protection for software inventions can be challenging - but we can help
James Leach - September 26, 2022

Obtaining patent protection for software inventions can be challenging - but we can help

New developments in software are continuing to change the world we live in at a rapid pace. Patent ...

The firepower of Cloud Native thinking
James Leach - August 12, 2022

The firepower of Cloud Native thinking

Taylor Dolezal of the Cloud Native Computing Foundation explains why the tech industry reveres this ...

Software Inventions: UKIPO and EPO approaches to patent eligibility Special Report
James Leach - September 15, 2021

Software Inventions: UKIPO and EPO approaches to patent eligibility Special Report

Our new Special Report, Software Inventions: UKIPO and EPO approaches to patent eligibility, has ...

EPO Opposition Trends in Engineering, Electronics and Software Special Report
Helen Bower - May 10, 2021

EPO Opposition Trends in Engineering, Electronics and Software Special Report

In autumn 2020, we analysed more than 8000 opposition cases filed at the European Patent Office ...

EPO confirms that the COMVIK approach to assessing patent eligibility is applicable to computer simulations (G1/19)
James Leach - March 11, 2021

EPO confirms that the COMVIK approach to assessing patent eligibility is applicable to computer simulations (G1/19)

The Enlarged Board of Appeal (EBoA) has now issued their decision G1/19, which concerns the ...

Software inventions at the European Patent Office: an in-depth study
James Leach - December 7, 2020

Software inventions at the European Patent Office: an in-depth study

It is sometimes difficult to obtain patent protection for inventions relating to software, in part ...

Light speed AI: sci-fi buzzwords or computing reality?
James Leach - September 9, 2020

Light speed AI: sci-fi buzzwords or computing reality?

In recent years, there has been rapid acceleration in quantum computing development and industry ...

Five things you (really) need to know about patenting software in Europe
James Leach - August 12, 2020

Five things you (really) need to know about patenting software in Europe

We often receive enquiries asking whether a particular software-related invention might be eligible ...

Antimicrobial resistance: moving towards a targeted approach
James Leach - August 10, 2020

Antimicrobial resistance: moving towards a targeted approach

Spectromics is working to put our existing arsenal of antibiotics to best use in the fight against ...

AI: Machine learning - the when’s and the how’s of machine learning
James Leach - January 20, 2020

AI: Machine learning - the when’s and the how’s of machine learning

In our recent post on the use of artificial intelligence in bioinformatics, it was highlighted that ...

AI: Machine learning - what is the machine actually learning?
James Leach - December 13, 2019

AI: Machine learning - what is the machine actually learning?

Following on from Richard Johnson’s blog post “Inventive AI: can machines innovate?” we now focus ...

More

  • Slavery Act
  • Legal Notices
  • Terms and Conditions
  • Privacy
  • Forward Community Programme
  • Login to MyMewburn
  • Join Mewburn Ellis

Follow us

Subscribe

Sign up to Forward: news, insights and features from Mewburn Ellis

Contact

  • mail@mewburn.com
  • London:

    +44 (0)20 7776 5300
  • Bristol:

    +44 (0)117 945 1234
  • Cambridge:

    +44 (0)1223 420383
  • Manchester:

    +44 (0)161 2477 722
  • Munich:

    +49 (0)89 244 459800

Copyright © 2025 Mewburn Ellis. All rights reserved. Terms and Conditions & Online Privacy